Medication adherence in type 2 diabetes: The ENTRED study 2007, a French population-based study

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Tiv, Michel ^a   Viel, Jean François ^a   Mauny, Frédéric ^a   Eschwège, Eveline ^b   Weill, Alain ^c   Fournier, Cécile ^d   Fagot Campagna, Anne ^e   Penfornis, Alfred ^f  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b INSERM   (France)

^c Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^d Institute for Health Prevention and Education (Inpes)   (France)

^e Institute of Public Health Surveillance (InVS)   (France)

^f UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ARTICLE; ATTITUDE TO ILLNESS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECONOMIC ASPECT; FAMILY RELATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT DECISION MAKING; RISK FACTOR; SELF REPORT; SOCIAL SUPPORT; TREATMENT DURATION; ADOLESCENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SELF REPORT; YOUNG ADULT;

EID: 84857775208     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032412     Document Type: Article

References (45)

1. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. National Institute for Health and Clinical Excellence (2008) NICE clinical guideline 66. Type 2 diabetes: the management of type 2 diabetes. Available: http://www.nice.org.uk/nicemedia/pdf/CG66NICEGuideline.pdf. Accessed 2011 June 18.
3. (2007) [Medical treatment of type 2 diabetes. Recommendations for good practice]. Diabetes Metab 33: 1S7-25.
4. Campbell SM, Roland MO, Middleton E, Reeves D, (2005) Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study. BMJ 331: 1121.
5. Pornet C, Bourdel-Marchasson I, Lecomte P, Eschwege E, Romon I, et al. (2011) Trends in the quality of care for elderly people with type 2 diabetes: the need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys). Diabetes Metab 37: 152-161.
6. World Health Organization (2003) Adherence to long term therapies, time for action Geneva World Health Organization.
7. Cramer JA, (2004) A systematic review of adherence with medications for diabetes. Diabetes Care 27: 1218-1224.
8. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS, (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43: 521-530.
9. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL, (2006) Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface 19: 31-41.
10. DiMatteo MR, (2004) Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42: 200-209.
11. Osterberg L, Blaschke T, (2005) Adherence to medication. N Engl J Med 353: 487-497.
12. Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, et al. (2006) Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care 29: 1997-2002.
13. Paes AH, Bakker A, Soe-Agnie CJ, (1997) Impact of dosage frequency on patient compliance. Diabetes Care 20: 1512-1517.
14. Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, et al. (2003) Neuropsychological correlates of suboptimal adherence to metformin. J Behav Med 26: 349-360.
15. Ciechanowski PS, Katon WJ, Russo JE, (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160: 3278-3285.
16. Donnan PT, MacDonald TM, Morris AD, (2002) Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 19: 279-284.
17. Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E, (2002) Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther 24: 460-467.
18. Venturini F, Nichol MB, Sung JC, Bailey KL, Cody M, et al. (1999) Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 33: 281-288.
19. Dezii CM, Kawabata H, Tran M, (2002) Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 95: 68-71.
20. Grant RW, Devita NG, Singer DE, Meigs JB, (2003) Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 26: 1408-1412.
21. Grant RW, Devita NG, Singer DE, Meigs JB, (2003) Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother 37: 962-969.
22. Brown JB, Nichols GA, Glauber HS, Bakst A, (1999) Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus. Clin Ther 21: 1045-1057.
23. Adams AS, Trinacty CM, Zhang F, Kleinman K, Grant RW, et al. (2008) Medication adherence and racial differences in A1C control. Diabetes Care 31: 916-921.
24. Trinacty CM, Adams AS, Soumerai SB, Zhang F, Meigs JB, et al. (2009) Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res 9: 24.
25. van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, et al. (2009) Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiol Drug Saf 18: 983-991.
26. Park KA, Kim JG, Kim BW, Kam S, Kim KY, et al. (2010) Factors that Affect Medication Adherence in Elderly Patients with Diabetes Mellitus. Korean Diabetes J 34: 55-65.
27. Pollack MF, Purayidathil FW, Bolge SC, Williams SA, (2010) Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 87: 204-210.
28. Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, et al. (2001) Evaluation de l'observance du traitement anti-hypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé. Presse Med 30: 1044-1048.
29. Mann DM, Ponieman D, Leventhal H, Halm EA, (2009) Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med 32: 278-284.
30. Rothenbacher D, Ruter G, Saam S, Brenner H, (2003) Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Pract 53: 389-391.
31. Nagasawa M, Smith MC, Barnes JH Jr, Fincham JE, (1990) Meta-analysis of correlates of diabetes patients' compliance with prescribed medications. Diabetes Educ 16: 192-200.
32. Ciechanowski PS, Katon WJ, Russo JE, Walker EA, (2001) The patient-provider relationship: attachment theory and adherence to treatment in diabetes. Am J Psychiatry 158: 29-35.
33. Lawton J, Peel E, Parry O, Douglas M, (2008) Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. Diabet Med 25: 491-495.
34. Parchman ML, Zeber JE, Palmer RF, (2010) Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med 8: 410-417.
35. Moreau A, Aroles V, Souweine G, Flori M, Erpeldinger S, et al. (2009) Patient versus general practitioner perception of problems with treatment adherence in type 2 diabetes: from adherence to concordance. Eur J Gen Pract 15: 147-153.
36. Cegala DJ, Marinelli T, Post D, (2000) The effects of patient communication skills training on compliance. Arch Fam Med 9: 57-64.
37. Magadza C, Radloff SE, Srinivas SC, (2009) The effect of an educational intervention on patients' knowledge about hypertension, beliefs about medicines, and adherence. Res Social Adm Pharm 5: 363-375.
38. Mosnier-Pudar H, Hochberg G, Eschwege E, Virally ML, Halimi S, et al. (2009) How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey. Diabetes Metab 35: 220-227.
39. Schechter CB, Walker EA, (2002) Improving adherence to diabetes self-management recommendations. Diabetes Spectrum 15: 170-175.
40. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB, (2004) The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 42: 649-652.
41. Schectman JM, Nadkarni MM, Voss JD, (2002) The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25: 1015-1021.
42. Guillausseau PJ, (2003) Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab 29: 79-81.
43. Penfornis A, (2003) Drug compliance in type 2 diabetes: role of drug treatment regimens and consequences on their benefits. Diabetes Metab 29 (3): S31-37.
44. Little RJ, Vartivarian S, (2003) On weighting the rates in non-response weights. Stat Med 22: 1589-1599.
45. Lepkowski JM, Mosher WD, Davis KE, Groves RM, van Hoewyk J, et al. (2006) National Survey of Family Growth, Cycle 6: sample design, weighting, imputation, and variance estimation. Vital Health Stat 2: 1-82.